Hi Stolly - Another thing - I reckon that EPT have already done some sort of unofficail PMLE study- and it worked! Why would they up the anti of the PMLE study to a multi country level if it was going to be a flop? A succsessful PMLE study will mean that about 15% of North Americans and Northern Europeans MUST use Melanotan to avoid the unsightly and uncomfortable effects that PMLE delivers. I think/hope Epitan plans to `go it alone' and take Melantoan to market themselves.
I like where this company is going at the moment.
MB
Hi Stolly - Another thing - I reckon that EPT have already done...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.37 |
Change
0.130(0.85%) |
Mkt cap ! $770.0M | |||
| Open | High | Low | Value | Volume |
| $15.36 | $15.54 | $15.18 | $1.274M | 82.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 237 | $15.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 282 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |